Barrow, Hanley, Mewhinney & Strauss
MR

Barrow, Hanley, Mewhinney & Strauss’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-17,789
Closed -$486K – 347
2015
Q1 		$486K Buy
+17,789
New +$490K ﹤0.01% 322

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CCMH
Cornerstone Capital Management Holdings New York $14.3B AUM 33.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's MR Position: Q2 2015 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2015, closing a stake of 17,789 shares — an estimated $486K sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in MR in Q1 2015 and held it in 1 quarter. The position peaked at $486K in Q1 2015. 118 funds tracked by Wall St. Rank hold MR as of Q2 2015.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q2 2015 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 17,789 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q2 2015, an estimated $486K.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q1 2015 and held it in 1 quarter.
  • Barrow, Hanley, Mewhinney & Strauss's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $486K in Q1 2015.
  • 118 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2015.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2015, filed 7 Aug 2015.